Research graph
References from Association of risk factors for venous thromboembolism and overall survival in lung cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
The incidence of cancer-associated thrombosis is increasing over time
10.1182/bloodadvances.2021005590 · 2022 · External reference
Venous thromboembolism in cancer patients: a population-based cohort study
10.1182/blood.2020007338 · 2021 · External reference
Cancer therapy-associated thrombosis
10.1161/atvbaha.120.314378 · 2021 · External reference
Epidemiology of first and recurrent venous thromboembolism in patients with active cancer. A population-based cohort study
10.1160/th15-08-0686 · 2017 · External reference
Survival after cancer-related venous thrombosis: the Scandinavian Thrombosis and Cancer study
10.1182/bloodadvances.2022009577 · 2023 · External reference
Venous thromboembolism and prognosis in cancer
10.1016/j.thromres.2009.12.023 · 2010 · External reference
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE
10.1007/s11239-020-02180-x · 2020 · External reference
A modified Khorana score as a risk assessment tool for predicting venous thromboembolism in newly diagnosed advanced lung cancer
10.1007/s11239-021-02396-5 · 2021 · External reference
Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer
10.1111/jth.13378 · 2016 · External reference
Rivaroxaban for thromboprophylaxis in high-risk ambulatory patients with cancer
10.1056/nejmoa1814630 · 2019 · External reference
Apixaban to prevent venous thromboembolism in patients with cancer
10.1056/nejmoa1814468 · 2019 · External reference
Development and validation of a predictive model for chemotherapy-associated thrombosis
10.1182/blood-2007-10-116327 · 2008 · External reference
The Khorana score for prediction of venous thromboembolism in cancer patients: a systematic review and meta-analysis
10.3324/haematol.2018.209114 · 2019 · External reference
Increased incidence of venous thromboembolism with cancer immunotherapy
10.1016/j.medj.2021.02.002 · 2021 · External reference
Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors
10.1007/s11239-022-02649-x · 2022 · External reference
Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support
10.1016/j.jbi.2008.08.010 · 2009 · External reference
The REDCap consortium: building an international community of software platform partners
10.1016/j.jbi.2019.103208 · 2019 · External reference
Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy
10.1182/blood.2020007878 · 2021 · External reference
Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer
10.1136/jitc-2022-006072 · 2023 · External reference
Khorana score: new predictor of early mortality in patients with lung adenocarcinoma
10.1177/1076029618777153 · 2018 · External reference
